HIV-1 プロテアゼ/阻害剤複合体における界面水の拘束力のある自由エネルギー貢献
Yipin Lu1, Chao-Yie Yang, Shaomeng Wang
1Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
Journal of the American Chemical Society
|September 7, 2006
まとめ
インターフェイスの水分子は,タンパク質-リガンド結合の自由エネルギーに著しく影響を与えます. 彼らの貢献は,タンパク質残留物や阻害物質の影響を受け,薬剤設計において極めて重要です.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- コンピューティング・ケミストリー
背景:
- タンパク質-リガンド複合体の水分子は,結合相互作用に不可欠である.
- 界面水のエネルギー貢献を定量化することは,結合を理解するために不可欠です.
- 水媒介結合に影響を及ぼす要因は,薬剤設計において明らかにする必要がある.
研究 の 目的:
- 個々の界面水分子の結合自由エネルギー貢献を定量的に評価する.
- タンパク質のプロトネーション状態と阻害物質が水の貢献に及ぼす影響を調査する.
- HIV-1 プロテアゼ阻害剤との相互作用における界面水の役割を理解する.
主な方法:
- 二重解離自由エネルギー分子ダイナミクスシミュレーション法を用いた.
- 4つの界面水分子の結合自由エネルギー貢献を計算した.
- 触媒アスパルテート残基プロトネーション状態 (Asp25,Asp125) と異なる阻害剤の影響を分析した.
主要な成果:
- 4つの界面水分子のうち2つは,自由エネルギー結合に大きく貢献した.
- 他の2つの水分子はゼロに近い結合自由エネルギー貢献を示した.
- 保存された水分子のWat301の貢献は,Asp25/Asp125プロトネーションと阻害剤のタイプによって強く影響を受けました.
結論:
- インターフェイスの水分子は,タンパク質-リガンド結合エネルギーにおいて,異なる役割を果たします.
- 鍵となる残留物のプロトネーション状態と阻害剤の選択は,水の貢献を調節する.
- 発見は,インターフェースの水相互作用を組み込むことの重要性を強調することによって,構造ベースの薬物設計にインフォームします.
関連する概念動画
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
01:29Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...